Inspire Medical Systems Inc $ 249.25 16.46 (7.07%)
Volume:
270,640
Avg Vol (1m):
234,562
Market Cap $:
6.76 Bil
Enterprise Value $:
6.56 Bil
PE Ratio:
0.00
PB Ratio:
29.28
Financial Strength | 6/10 |
Current | Vs Industry | Vs History | |
---|---|---|---|
Cash-To-Debt | 7.65 | ||
Equity-to-Asset | 0.82 | ||
Debt-to-Equity | 0.13 | ||
Debt-to-EBITDA | -0.57 | ||
Piotroski F-Score | 4 | ||
Altman Z-Score | 73.31 | ||
Beneish M-Score | -2.13 | ||
WACC vs ROIC |
Profitability Rank | 3/10 |
Current | Vs Industry | Vs History | |
---|---|---|---|
Operating Margin % | -48.72 | ||
Net Margin % | -49.58 | ||
ROE % | -29.81 | ||
ROA % | -24.42 | ||
ROC (Joel Greenblatt) % | -345.34 | ||
3-Year Revenue Growth Rate | 27.9 | ||
3-Year EBITDA Growth Rate | -21.9 | ||
3-Year EPS without NRI Growth Rate | -15.8 |
INSP
Valuation Rank |
Current | Vs Industry | Vs History | |
---|---|---|---|
PB Ratio | 29.28 | ||
PS Ratio | 56.82 | ||
EV-to-EBIT | -119.29 | ||
EV-to-EBITDA | -121.15 | ||
EV-to-Revenue | 56.83 | ||
Current Ratio | 13.02 | ||
Quick Ratio | 12.61 | ||
Days Inventory | 167.72 | ||
Days Sales Outstanding | 79.29 | ||
Days Payable | 149.31 |
Dividend & Buy Back |
Current | Vs Industry | Vs History | |
---|---|---|---|
3-Year Average Share Buyback Ratio | -24.6 |
Valuation & Return |
Current | Vs Industry | Vs History | |
---|---|---|---|
Price-to-Tangible-Book | 29.29 | ||
Earnings Yield (Greenblatt) % | -0.85 |